ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

RPTX Repare Therapeutics Inc

3.45
0.10 (2.99%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Repare Therapeutics Inc RPTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.10 2.99% 3.45 23:00:07
Open Price Low Price High Price Close Price Previous Close
3.48 3.445 3.74 3.45 3.35
more quote information »

Recent News

Date Time Source Heading
4/30/202406:05BWDEBIOPHARM ET REPARE THERAPEUTICS ANNONCENT LE TRAITEMENT..
4/26/202415:05BWRepare Therapeutics Appoints Steven H. Stein, M.D. to its..
3/05/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202420:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202420:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/29/202406:05BWRepare Therapeutics to Participate in Two Upcoming Investor..
2/28/202415:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
2/28/202406:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/28/202406:10EDGAR2Form 8-K - Current report
2/28/202406:05BWRepare Therapeutics Provides Business Update and Reports..
2/15/202406:05BWRepare Therapeutics Doses First Patient in Phase 1 Clinical..
2/14/202420:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/14/202407:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202415:48EDGAR2Form 8-K - Current report
2/12/202415:05BWRepare Therapeutics to Regain Global Rights to Camonsertib
1/25/202413:29EDGAR2Form 8-K - Current report
1/25/202406:00BWRepare Therapeutics Announces Achievement of $40 Million..
1/12/202415:05EDGAR2Form 8-K - Current report
1/08/202406:00BWRepare Therapeutics Provides Corporate Update and Highlights..
1/04/202415:05BWRepare Therapeutics and Debiopharm Partner to Explore the..
12/29/202315:05BWRepare Therapeutics Insiders Establish Automatic Securities..
12/12/202315:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/15/202306:20EDGAR2Form 8-K - Current report
11/15/202306:00BWRepare Therapeutics Unveils Two Programs Expected to Enter..
11/09/202306:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202306:05EDGAR2Form 8-K - Current report
11/09/202306:00BWRepare Therapeutics Provides Business Update and Reports..
11/07/202306:00BWRepare Therapeutics to Host Investor and Analyst Conference..
11/06/202306:00BWRepare Therapeutics to Participate in Two Upcoming Investor..
10/13/202316:15EDGAR2Form 8-K - Current report
10/13/202308:47EDGAR2Form 8-K - Current report
10/13/202308:40BWRepare Therapeutics Announces Positive Initial Data from..
10/06/202306:56EDGAR2Form 8-K - Current report
10/03/202306:00BWRepare Therapeutics to Host Conference Call and Webcast to..
9/19/202306:00BWRepare Therapeutics to Present Preliminary Phase 1 MYTHIC..
9/06/202306:00BWRepare Therapeutics to Participate at the Morgan Stanley..
8/09/202315:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/09/202315:09EDGAR2Form 8-K - Current report
8/09/202315:05BWRepare Therapeutics Provides Business Update and Reports..
6/08/202306:00BWRepare Therapeutics to Participate at the Goldman Sachs 44th..
6/07/202315:05BWRepare Therapeutics Reports Proof of Concept for Lunresertib..
6/06/202306:00BWRepare Therapeutics Announces Publication in Nature Medicine..
6/02/202306:00BWRepare Therapeutics to Host Conference Call and Webcast to..
5/22/202306:00BWRepare Reports Inducement Grant Under Nasdaq Listing Rule..
5/09/202315:05BWRepare Therapeutics Provides Business Update and Reports..

Your Recent History

Delayed Upgrade Clock